ACE Pharmaceuticals B.V. operates in the pharmaceutical industry and focuses on the development and production of essential and niche medicines for patients with specific medical needs. The company plays a vital role in maintaining the availability of small-scale or discontinued medications that still hold therapeutic value. It works closely with healthcare professionals, hospitals, and pharmacists to ensure safe and compliant access to specialized treatments. ACE is known for its commitment to quality, flexibility, and patient-centric innovation.
Challenge
The product portfolio increased in complexity by increased number of skus and higher rotation of phase in/phase out. The current way of planning was push where pull was required. The issues faced where high stock, stock outs and risk of write offs which can be solved by supply chain planning enhancements. We were asked to assess the current state/maturity of their S&OP process, development of a roadmap and manage the implementation.
Key benefits
Lower stock and strong decrease of write off (risks), increased collaboration between departments, improved efficiency by optimizing their planning tool and reports.
What we did
- S&OP assessment by reviewing their current state of critical KPI’s (stock level, service level, forecast accuracy/bias) and interviews with key stakeholders of their planning process
- Review of their current tooling landscape
- Delivered a plan to implement a tailored S&OP cycle with common steps (demand planning, portfolio review, supply planning, S&OP meeting)
- Developed agenda’s, roles and responsibilities, required reporting/tools to facilitate these S&OP meetings
- Trained the team how S&OP works for their organization and attended/coached the S&OP meetings for four runs in time and within budget during a running operation
